Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMID 16909220)

Published in Eur Radiol on August 15, 2006

Authors

Yoshiko Hayashida1, Toshitake Yakushiji, Kazuo Awai, Kazuhiro Katahira, Yoshiharu Nakayama, Osamu Shimomura, Mika Kitajima, Toshinori Hirai, Yasuyuki Yamashita, Hiroshi Mizuta

Author Affiliations

1: Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-0811, Japan. 1-doll@tb3.so-net.ne.jp

Articles citing this

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44

Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol (2008) 2.84

Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging (2010) 1.82

Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology (2012) 1.76

A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia (2007) 1.50

New insights into tumor microstructure using temporal diffusion spectroscopy. Cancer Res (2008) 1.25

Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol (2007) 1.25

Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol (2007) 1.23

Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review. Skeletal Radiol (2011) 1.21

ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma. Neuroradiology (2010) 1.20

The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol (2009) 1.11

Comparisons of the efficacy of a Jak1/2 inhibitor (AZD1480) with a VEGF signaling inhibitor (cediranib) and sham treatments in mouse tumors using DCE-MRI, DW-MRI, and histology. Neoplasia (2012) 1.10

Diagnostic ability of apparent diffusion coefficients for lymphomas and carcinomas in the pharynx. Eur Radiol (2007) 1.01

Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis. Pediatr Radiol (2010) 1.00

Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging (2011) 1.00

Diffusion-weighted and diffusion tensor imaging for pediatric musculoskeletal disorders. Pediatr Radiol (2007) 0.98

Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study. Br J Radiol (2009) 0.96

The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. Eur Radiol (2009) 0.95

Diffusion-weighted MR imaging for characterizing musculoskeletal lesions. Radiographics (2014) 0.93

Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers. Clin Cancer Res (2010) 0.90

Therapy response with diffusion MRI: an update. Cancer Imaging (2012) 0.87

A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Transl Oncol (2014) 0.85

Evaluation of static and dynamic MRI for assessing response of bone sarcomas to preoperative chemotherapy: Correlation with histological necrosis. Indian J Radiol Imaging (2015) 0.84

Whole-body MR imaging, bone diffusion imaging: how and why? Pediatr Radiol (2010) 0.83

MR findings of primary bone lymphoma in a 15-year-old girl: emphasis on diffusion-weighted imaging. Pediatr Radiol (2010) 0.83

Effect of b value on monitoring therapeutic response by diffusion-weighted imaging. World J Gastroenterol (2008) 0.83

Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study. PLoS One (2013) 0.83

Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis. Magn Reson Imaging (2015) 0.82

Applications of molecular imaging. Prog Mol Biol Transl Sci (2010) 0.81

Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results. Skeletal Radiol (2012) 0.81

Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer. NMR Biomed (2015) 0.79

Diagnostic Performance of Diffusion-weighted Magnetic Resonance Imaging in Bone Malignancy: Evidence From a Meta-Analysis. Medicine (Baltimore) (2015) 0.78

The role of magnetic resonance imaging in the evaluation of bone tumours and tumour-like lesions. Insights Imaging (2014) 0.77

Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size. Surg Today (2015) 0.76

Surface-to-volume ratio mapping of tumor microstructure using oscillating gradient diffusion weighted imaging. Magn Reson Med (2015) 0.76

Diffusion-weighted imaging in musculoskeletal radiology-clinical applications and future directions. Quant Imaging Med Surg (2015) 0.76

Diffusion-weighted Magnetic Resonance Imaging in the Diagnosis of Bone Tumors: Preliminary Results. J Clin Imaging Sci (2013) 0.76

Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage. World J Gastroenterol (2017) 0.75

Imaging 'the lost tribe': a review of adolescent cancer imaging. Part 1. Cancer Imaging (2009) 0.75

Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology. Clin Transl Imaging (2016) 0.75

Pulsed and oscillating gradient MRI for assessment of cell size and extracellular space (POMACE) in mouse gliomas. NMR Biomed (2016) 0.75

Whole-body diffusion-weighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study. Cancer Imaging (2013) 0.75

Value of diffusion-weighted imaging for evaluating chemotherapy response in osteosarcoma: A meta-analysis. Mol Clin Oncol (2017) 0.75

Articles cited by this

Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med (1977) 2.06

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol (1998) 1.81

Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology (1992) 1.61

Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients. Radiology (1982) 1.46

Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology (2005) 1.35

Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging. Radiology (1998) 1.33

Diffusion-weighted MRI in the characterization of soft-tissue tumors. J Magn Reson Imaging (2002) 1.33

Diffusion-weighted MRI of soft tissue tumours. Eur Radiol (2004) 1.26

Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology (2003) 1.22

Musculoskeletal neoplasms: static and dynamic Gd-DTPA--enhanced MR imaging. Radiology (1989) 1.15

Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR Am J Roentgenol (1995) 1.11

Combined perfusion- and diffusion-weighted MR imaging in acute ischemic stroke during the 1st week: a longitudinal study. Radiology (2000) 1.05

Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol (2000) 1.00

Diffusion-weighted imaging of tumor recurrencies and posttherapeutical soft-tissue changes in humans. Eur Radiol (2001) 0.98

Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology (1990) 0.91

Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology (1992) 0.90

Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology (1992) 0.90

Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med (1996) 0.82

Osteosarcoma: angiographic assessment of response to preoperative chemotherapy. Radiology (1989) 0.81

Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy. Cancer (1999) 0.80

Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma. Cancer (1997) 0.78

Can conventional radiographs be used to monitor the effect of neoadjuvant chemotherapy in patients with osteogenic sarcoma? Skeletal Radiol (1996) 0.78

Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol (1992) 0.78

Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. Invest Radiol (1992) 0.78

Response of osteosarcoma to preoperative intravenous high-dose methotrexate chemotherapy: CT evaluation. AJR Am J Roentgenol (1985) 0.77

Changes in tumor perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy. Radiology (1994) 0.76

The angiographic response of osteosarcoma following pre-operative chemotherapy. Skeletal Radiol (1986) 0.75

Dynamic, gadolinium-enhanced MR imaging to monitor tumor response to chemotherapy. Radiology (1993) 0.75

Articles by these authors

Radiation dose reduction without degradation of low-contrast detectability at abdominal multisection CT with a low-tube voltage technique: phantom study. Radiology (2005) 2.51

Abdominal CT with low tube voltage: preliminary observations about radiation dose, contrast enhancement, image quality, and noise. Radiology (2005) 2.21

Differential diagnosis of ground-glass opacity nodules: CT number analysis by three-dimensional computerized quantification. Chest (2007) 2.13

Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial. J Am Coll Cardiol (2010) 2.11

Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol (2005) 1.81

Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging. Radiology (2007) 1.59

Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien) (2012) 1.57

Association of epicardial and abdominal visceral adipose tissue with coronary atherosclerosis in patients with a coronary artery calcium score of zero. Circ J (2015) 1.56

The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. Arterioscler Thromb Vasc Biol (2010) 1.56

Diffusion-weighted magnetic resonance for pulmonary nodules: 1.5 vs. 3 Tesla. Asian Cardiovasc Thorac Ann (2011) 1.50

Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology (2005) 1.49

Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol (2008) 1.47

Association between serum levels of n-3 polyunsaturated fatty acids and coronary plaque detected by coronary computed tomography angiography in patients receiving statin therapy. Circ J (2013) 1.44

Prediction of left main or 3-vessel disease using myocardial perfusion reserve on dynamic thallium-201 single-photon emission computed tomography with a semiconductor gamma camera. Circ J (2015) 1.43

Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol (2010) 1.40

Spinal MR findings in continuous epidural analgesia without infection. AJNR Am J Neuroradiol (2005) 1.40

Machine Learning to Predict the Rapid Growth of Small Abdominal Aortic Aneurysm. J Comput Assist Tomogr (2020) 1.39

Detection of hemorrhagic hypointense foci in the brain on susceptibility-weighted imaging clinical and phantom studies. Acad Radiol (2007) 1.37

Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol (2008) 1.34

Automated hepatic volumetry for living related liver transplantation at multisection CT. Radiology (2006) 1.32

Nonoperative management of unruptured visceral artery aneurysms: treatment by transcatheter coil embolization. J Vasc Surg (2008) 1.30

Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis (2009) 1.29

Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother Oncol (2007) 1.29

Combination of a low-tube-voltage technique with hybrid iterative reconstruction (iDose) algorithm at coronary computed tomographic angiography. J Comput Assist Tomogr (2011) 1.27

Endovascular management of visceral artery pseudoaneurysms: transcatheter coil embolization using the isolation technique. Cardiovasc Intervent Radiol (2010) 1.26

Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system. J Gastroenterol (2011) 1.25

A functional polymorphism in THBS2 that affects alternative splicing and MMP binding is associated with lumbar-disc herniation. Am J Hum Genet (2008) 1.25

Whole-body diffusion-weighted magnetic resonance imaging. Eur J Radiol (2009) 1.25

Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol (2010) 1.23

Lower tube voltage reduces contrast material and radiation doses on 16-MDCT aortography. AJR Am J Roentgenol (2006) 1.21

Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: Assessment with computer-aided three-dimensional volumetry. Acad Radiol (2011) 1.18

T1ρ and T2 mapping reveal the in vivo extracellular matrix of articular cartilage. J Magn Reson Imaging (2011) 1.18

Coronary arterial malformation depicted at multi-slice CT angiography. Int J Cardiovasc Imaging (2006) 1.17

Low-kilovoltage, high-tube-current MDCT of liver in thin adults: pilot study evaluating radiation dose, image quality, and display settings. AJR Am J Roentgenol (2011) 1.17

Association between epicardial adipose tissue volume and characteristics of non-calcified plaques assessed by coronary computed tomographic angiography. Int J Cardiol (2011) 1.16

Arthroscopic repair of traumatic combined rotator cuff tears involving the subscapularis tendon. J Bone Joint Surg Am (2007) 1.16

Computer-aided volumetry of pulmonary nodules exhibiting ground-glass opacity at MDCT. AJR Am J Roentgenol (2010) 1.15

Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology (2007) 1.15

Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology (2004) 1.14

Hepatocellular carcinoma in patients weighing 70 kg or less: initial trial of compact-bolus dynamic CT with low-dose contrast material at 80 kVp. AJR Am J Roentgenol (2011) 1.14

Macroscopic separation of dense fluid phase and liquid phase of phosphorus. Science (2004) 1.13

The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol (2009) 1.11

Low contrast agent and radiation dose protocol for hepatic dynamic CT of thin adults at 256-detector row CT: effect of low tube voltage and hybrid iterative reconstruction algorithm on image quality. Radiology (2012) 1.10

Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2007) 1.09

Pulmonary nodules: estimation of malignancy at thin-section helical CT--effect of computer-aided diagnosis on performance of radiologists. Radiology (2006) 1.09

Comparison of standard- and low-tube voltage MDCT angiography in patients with peripheral arterial disease. Eur Radiol (2010) 1.08

Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases. Radiology (2005) 1.08

Evaluation of diffusion-weighted imaging for the differential diagnosis of poorly contrast-enhanced and T2-prolonged bone masses: Initial experience. J Magn Reson Imaging (2006) 1.06

Coil embolization of pancreaticoduodenal artery aneurysms associated with celiac artery stenosis: report of three cases. Cardiovasc Intervent Radiol (2007) 1.05

Clinical usefulness of unsubtracted 3D digital angiography compared with rotational digital angiography in the pretreatment evaluation of intracranial aneurysms. AJNR Am J Neuroradiol (2003) 1.04

Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology (2009) 1.04

Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis. Arthritis Rheum (2004) 1.03

Ability of diffusion-weighted imaging for the differential diagnosis between chronic expanding hematomas and malignant soft tissue tumors. J Magn Reson Imaging (2008) 1.02

Usefulness of diffusion-weighted imaging in the localization of prostate cancer. Int J Radiat Oncol Biol Phys (2008) 1.02